Sinsin Pharmaceutical Co. Ltd (002800) — Free Cash Flow Generation Index
Sinsin Pharmaceutical Co. Ltd (002800) has a Free Cash Flow Generation Index of 0.81x as of September 2025. Free cash flow of ₩3.83 Billion represents 1% of operating cash flow (₩4.70 Billion). Read 002800 total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sinsin Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2015–2024)
Historical FCF Generation Index trend for Sinsin Pharmaceutical Co. Ltd across 9 annual periods. Explore reinvestment intensity of Sinsin Pharmaceutical Co. Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Sinsin Pharmaceutical Co. Ltd (2015–2024)
Year-by-year Free Cash Flow Generation Index for Sinsin Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see Sinsin Pharmaceutical Co. Ltd market capitalisation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.75x | ₩4.43 Billion | ₩5.94 Billion | ₩1.51 Billion | ▲ +366.9% |
| 2023 | -0.28x | ₩-1.10 Billion | ₩3.93 Billion | ₩5.03 Billion | ▼ -134.5% |
| 2022 | 0.81x | ₩4.42 Billion | ₩5.46 Billion | ₩907.13 Million | ▲ +100.7% |
| 2021 | -114.70x | ₩-2.66 Billion | ₩23.18 Million | ₩2.68 Billion | ▼ -1979.4% |
| 2020 | -5.52x | ₩-10.29 Billion | ₩1.87 Billion | ₩11.97 Billion | ▼ -116.3% |
| 2018 | 33.86x | ₩26.21 Billion | ₩774.24 Million | ₩25.44 Billion | ▲ +1800.2% |
| 2017 | 1.78x | ₩8.14 Billion | ₩4.57 Billion | ₩3.57 Billion | ▼ -51.3% |
| 2016 | 3.66x | ₩10.22 Billion | ₩2.79 Billion | ₩7.43 Billion | ▲ +83.2% |
| 2015 | 2.00x | ₩10.46 Billion | ₩5.24 Billion | ₩5.22 Billion | — |